Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New developments in hereditary hemochromatosis.

V J Felitti1, E Beutler

  • 1Department of Preventive Medicine, Kaiser Permanente, San Diego, California, USA.

The American Journal of the Medical Sciences
|October 16, 1999
PubMed
Summary

Hereditary hemochromatosis, caused by HFE gene mutations, leads to excess iron absorption and organ damage. Early diagnosis via transferrin saturation and treatment with phlebotomy are crucial for normal lifespan.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

1342C mutation in Gaucher's disease.

Lancet (London, England)·1995
Same author

Triosephosphate isomerase deficiency: repetitive occurrence of point mutation in amino acid 104 in multiple apparently unrelated families.

American journal of hematology·1995
Same author

Gaucher disease.

Medicine·1995
Same author

Treatment regimens in Gaucher's disease.

Lancet (London, England)·1995
Same author

Molecular study of pyruvate kinase deficient patients with hereditary nonspherocytic hemolytic anemia.

The Journal of clinical investigation·1995
Same author

Erythrocyte fragility and chronic intermittent pigmenturia in a dog.

Journal of the American Veterinary Medical Association·1995

Area of Science:

  • Genetics
  • Gastroenterology
  • Endocrinology

Background:

  • Hereditary hemochromatosis involves mutations in the HLA class I gene HFE, leading to unregulated iron absorption.
  • Excess iron accumulation over time causes significant tissue damage, including cirrhosis, cardiomyopathy, diabetes, and arthropathies.
  • It is the most prevalent hereditary disorder among Northern Europeans, affecting approximately 5 in 1000 individuals.

Purpose of the Study:

  • To outline the pathophysiology, diagnosis, and management of hereditary hemochromatosis.
  • To emphasize the importance of early detection and intervention to prevent severe complications.
  • To highlight the necessity of genetic counseling for affected families.

Main Methods:

  • Screening for hereditary hemochromatosis using transferrin saturation (fasting value >50% is indicative).

Related Experiment Videos

  • Confirmation of iron overload through serial phlebotomy to assess iron storage.
  • Liver biopsy is generally not indicated unless in specific clinical scenarios.

    • Main Results:

    • Early diagnosis and treatment with phlebotomy can normalize lifespan.
    • Untreated hereditary hemochromatosis leads to a markedly shortened life expectancy due to progressive organ damage.
    • Genetic evaluation of first-degree relatives is essential for timely diagnosis and prevention.

    Conclusions:

    • Hereditary hemochromatosis requires prompt diagnosis and management through phlebotomy to avert serious health consequences.
    • Genetic screening and counseling are vital components of managing this common hereditary disease.
    • Effective treatment before the onset of tissue damage ensures a normal lifespan for affected individuals.